Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-03

Clinical Trial Update: Oxytocin and Cognitive Control in Adult ADHD [EARLY_Phase 1]

View source ↗

Summary

A completed EARLY_PHASE1 trial from Massachusetts General Hospital evaluated oxytocin for cognitive control in adults with Attention Deficit/Hyperactivity Disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit/Hyperactivity Disorder | EARLY_Phase 1 | Status: COMPLETED